+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Histone Deacetylase 6 - Pipeline Insight, 2024 - Product Thumbnail Image

Histone Deacetylase 6 - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Oncology Market in India 2025-2029 - Product Thumbnail Image

Oncology Market in India 2025-2029

  • Report
  • February 2025
  • 178 Pages
  • India
From
Gallbladder Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Gallbladder Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 166 Pages
  • Global
From
Allergy Rhinitis Drugs Market 2024-2028 - Product Thumbnail Image

Allergy Rhinitis Drugs Market 2024-2028

  • Report
  • November 2023
  • 165 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more